| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |